Myopia management, or control, has become an area of increasing interest within the optometric industry. Yet, contrary to the apparent enthusiasm among eye care professionals (ECPs), prescribing rates for at least some myopia management solutions have remained lower than expected.
Previous studies have attempted to gauge patient and practitioner interest in myopia management via surveys and focus groups. Such studies capture invaluable insights but tend to be population specific. Thus far, the use of larger datasets, or ‘big data’, to understand interest in myopia has remained limited.
The aim of this study was to understand global interest in myopia, methods of arresting myopia progression (contact lenses, spectacles, atropine, orthokeratology), and different types of refractive error (myopia, hyperopia, astigmatism). Unlike previous works, our study aimed to evaluate a much larger, global, dataset from which to draw conclusions.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here